News
Shuhiba Mohammad recently took her daughter for her routine childhood immunizations at age 1, and was frustrated when she was ...
Moderna’s LP.8.1-adapted COVID-19 vaccine has been recommended by the European Medicines Agency (EMA)’s human medicines ...
North Carolina Republican lawmakers overrode several vetoes by Gov. Josh Stein, getting just enough votes from Democrats to ...
(Reuters) -British drugmaker GSK expects annual sales and profit to be towards the top of its forecast range, after ...
8h
Asianet Newsable on MSNFDA Official Who Halted Sarepta’s Gene Therapy Resigns Amid Backlash Over Access To Duchenne TreatmentVinay Prasad resigned from the FDA after just two months in the role, following backlash over blocking access to Sarepta’s ...
Prasad's exit ends a tumultuous tenure during which he led a reworking of agency guidelines on COVID vaccines and his office ...
This risky biotech company faces significant challenges ahead. But it has already proven its worth and may be able to do so ...
Sound more like science fiction than actual science? Then, brace yourself because there are, at least, 15 breast cancer vaccine clinical trials in various stages in the U.S., some in phase II and III.
MRNA's second-quarter results are likely to spotlight a sharp decline in Spikevax sales, RSV uptake and key pipeline ...
Seattle media misrepresent declining vaccination rates among K-12 students in Washington state. Get the facts here.
HHS Secretary RFK Jr. vows to reform the Vaccine Injury Program, highlighting inefficiencies and favoritism in compensating ...
CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its investigational mRNA therapeutics have been accepted for presentation at the 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results